Furthermore, we demonstrated that TRIM9 promoted bladder cancer progression and chemoresistance through the regulation of cell proliferation, apoptosis, migration via CEACAM6-Smad2/3 signaling. The gene discussed is SMAD2; the disease is urinary bladder carcinoma.